Biomarkers of Oxidative Stress Study II: Are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
Maria B. Kadiiska(National Institutes of Health), J. Carl Barrett(Imperial College Healthcare NHS Trust), Deirdre M. Murray(University College Cork), Beth C. Gladen(National Institutes of Health), Joshua Rokach(Florida Institute of Technology), Garret A. FitzGerald(California University of Pennsylvania), Jay W. Heinecke(University of Washington), Mark K. Shigenaga, Dori R. Germolec(National Institute of Environmental Health Sciences), John A. Lawson(Universities UK), Jason D. Morrow(University of Ulster), B N Ames(University of California, Berkeley), Donna D. Baird(National Institute of Environmental Health Sciences), J. T. Wachsman(National Institutes of Health), Abraham Nyska(Tel Aviv University), Soumen Basu(Thapar Institute of Engineering & Technology), Patrick B. Walter(University of Victoria), Carol E. Parker(National Institutes of Health), Daniel Wellner(Cornell University), Magdalene M. George(Loyola University Medical Center), John P. Plastaras(Radiation Oncology Associates), Jing Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), L. Jackson Roberts(The University of Melbourne), David H. Van Thiel(University of Pittsburgh), LeRae Graham(National Institutes of Health), Robert A. Floyd(The University of Texas MD Anderson Cancer Center), Rajindar S. Sohal(University of Southern California), N Brot(La Roche College), L.J. Marnett(Vanderbilt University), K. B. Tomer(National Institutes of Health), Raymond R. Tice(Hillsborough Community College), Gary E. Hatch(Environmental Protection Agency), K. Hensley(Oklahoma Medical Research Foundation), Ronald P. Mason(National Institutes of Health)
Cited by 697
Related Papers
Oxidants, antioxidants, and the degenerative diseases of aging.
|Proceedings of the National Academy of Sciences|1993|6k
Prostaglandins and Inflammation
|Arteriosclerosis Thrombosis and Vascular Biology|2011|3.7k
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
|New England Journal of Medicine|2001|1.4k
Increase in Circulating Products of Lipid Peroxidation (F<sub>2</sub>-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
|New England Journal of Medicine|1995|1.3k
Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions.
|Journal of Clinical Investigation|1994|1.3k